Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CES1 | P23141 | 7/20 | 0.48 |
| ▸ | CES2 | O00748 | 6/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | FABP3 | P05413 | 3/20 | 0.37 |
| ▸ | FFAR3 | O14843 | 2/20 | 0.37 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.37 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.37 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.37 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29674645 | 0.96 | CES1 (0.52) | CA1CES1CES2ALDH1A1TP53 | |
| SCHEMBL18204926 | 0.91 | CES1 (0.52) | CA1CES1CES2ALDH1A1TP53 | |
| SCHEMBL28360314 | 0.91 | CES1 (0.52) | CA1CES1CES2ALDH1A1TP53 | |
| SCHEMBL11501483 | 0.91 | CES1 (0.52) | CA1CES1CES2ALDH1A1TP53 | |
| SCHEMBL18204924 | 0.91 | CES1 (0.52) | CA1CES1CES2ALDH1A1TP53 | |
| SCHEMBL11501484 | 0.91 | CES1 (0.52) | CA1CES1CES2ALDH1A1TP53 | |
| SCHEMBL2542366 | 0.91 | CES1 (0.52) | CA1CES1CES2ALDH1A1TP53 | |
| SCHEMBL18204920 | 0.91 | CES1 (0.52) | CA1CES1CES2ALDH1A1TP53 | |
| Zinc Ion SCHEMBL18204915 | 0.91 | CES1 (0.52) | CA1CES1CES2ALDH1A1TP53 | |
| Hydrochloric Acid SCHEMBL10363191 | 0.89 | CES1 (0.50) | CA1CES1CES2ALDH1A1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100197938-A1 | Process for producing indole compoud | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2010-08-05 | — | — | US | disclosed |
| US-20070083053-A1 | Process for producing indole compound | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2007-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100197938-A1 | Process for producing indole compoud | IDO1, IDO2, NOS2 | CA1 98/4885CES1 3248/4885CES2 845/4885 |
| US-20070083053-A1 | Process for producing indole compound | IDO2, IDO1, TDO2 | CA1 205/4885CES1 3795/4885CES2 1225/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.